Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glossopharyngeal Nerve Block for GERD-Induced Pharyngeal Dysphagia
NCT06328205Not yet recruiting
- Sponsor
- Copka Sonpashan
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Randomised, double-blind trial of lidocaine and cyanocobalamin in oropharyngeal dysphagia (2 arms), sponsored by Copka Sonpashan. Primary endpoint: Rosenbek penetration-aspiration scale at Day 10. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocainecyanocobalamin
03
Conditions
oropharyngeal dysphagia
Beyond the preview
Go deeper on NCT06328205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06328205.